$Eliem Therapeutics (ELYM.US)$ NEWS Eliem Therapeutics Annou...
NEWS
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Eliem Therapeutics, Inc. (ELYM) announces the acquisition of Tenet Medicines, Inc., focusing on advancing TNT119, an anti-CD19 antibody, for autoimmune diseases. The combined company expects to have $210 million in cash, including $120 million from a private placement. The acquisition aims to fund operations until 2027 and achieve key clinical milestones.
Eliem Therapeutics, Inc. (ELYM) announces the acquisition of Tenet Medicines, Inc., focusing on advancing TNT119, an anti-CD19 antibody, for autoimmune diseases. The combined company expects to have $210 million in cash, including $120 million from a private placement. The acquisition aims to fund operations until 2027 and achieve key clinical milestones.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
752Followers
75Following
4821Visitors
Follow